Becton, Dickinson and Company (NYSE:BDX) is a medical device company that develops and manufactures medical supplies, devices, laboratory equipment, and diagnostic products.

Becton, Dickinson and Company (BDX) has earned a grade of F for momentum. Its weighted relative strength of -12.2% translates into a Momentum Score of 14, indicating Very Weak momentum.

Becton, Dickinson and Co. BDX develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The 52-week range of Becton Dickinson stock ...

Shares of Becton Dickinson & Co. BDX shed 1.85% to $169.40 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.41% to ...

We recently compiled a list of the 10 Most Oversold Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Becton, Dickinson and Company (NYSE:BDX) stands ...

Shares of Becton Dickinson & Co. BDX shed 2.46% to $171.02 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.10% to ...

Becton, Dickinson and Company (NYSE:BDX) Tuesday announced the global commercial launch of the world's first cell analyzer featuring breakthrough spectral and real-time cell imaging technologies.

Wells Fargo & Company downgraded shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) from an overweight rating to an equal weight rating in a report released on Thursday, MarketBeat ...